相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The use of Toll-like receptor 7/8 agonists as vaccine adjuvants
John P. Vasilakos et al.
EXPERT REVIEW OF VACCINES (2013)
Induction of Potent Antigen-specific Cytotoxic T Cell Response by PLGA-nanoparticles Containing Antigen and TLR Agonist
Young-Ran Lee et al.
Immune Network (2013)
Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC)
Suzanne Ostrand-Rosenberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Newly Identified TLR9 Stimulant, M6-395 Is a Potent Polyclonal Activator for Murine B Cells
Mi-Hee Park et al.
Immune Network (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation
Holger Hackstein et al.
CELLULAR IMMUNOLOGY (2011)
Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
Srinivas Nagaraj et al.
CLINICAL CANCER RESEARCH (2010)
Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice
Hanh K. Le et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Altered macrophage differentiation and immune dysfunction in tumor development
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Holger Kanzler et al.
NATURE MEDICINE (2007)
TLR7/8 agonists impair monocyte-derived dendritic cell differentiation and maturation
Eric Assier et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
The terminology issue for myeloid-derived suppressor cells
Dmitry I. Gabrilovich et al.
CANCER RESEARCH (2007)
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
P Serafini et al.
SEMINARS IN CANCER BIOLOGY (2006)
Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression
SK Bunt et al.
JOURNAL OF IMMUNOLOGY (2006)
Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity
E Suzuki et al.
CLINICAL CANCER RESEARCH (2005)
Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease
P Sinha et al.
JOURNAL OF IMMUNOLOGY (2005)
Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery
LL Thomsen et al.
VACCINE (2004)
Toll-like receptor control of the adaptive immune responses
A Iwasaki et al.
NATURE IMMUNOLOGY (2004)
Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential
MA Stanley
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2002)
Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
M Jurk et al.
NATURE IMMUNOLOGY (2002)
Imiquimod and resiquimod as novel immunomodulators
DH Dockrell et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells
JK Lee et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans' cells
RP Burns et al.
CLINICAL IMMUNOLOGY (2000)
Vitamin D-3 treatment to diminish the levels of immune suppressive CD34(+) cells increases the effectiveness of adoptive immunotherapy
KM Wiers et al.
JOURNAL OF IMMUNOTHERAPY (2000)
分享论文
